Operating Leases Operating Leased Assets [Line Items] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Statistical Measurement [Domain] Statistical Measurement [Domain] Total current assets Assets, Current Research and development Research and Development Expense Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Schedule of Third-party Payers as a Percentage of Total Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Acquisition-related contingent consideration, net of current portion Business Combination, Contingent Consideration, Liability Supplementary cash flow information: Supplemental Cash Flow Information [Abstract] Award Type [Domain] Award Type [Domain] Contract manufacturing and testing Biopharmaceutical And Other - Contract Manufacturing And Testing [Member] Biopharmaceutical And Other - Contract Manufacturing And Testing Finance lease, right-of-use asset, statement of financial position [Extensible List] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other income, net Other income, net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Purchase of short-term investments Payments to Acquire Held-to-Maturity Securities Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Effect of foreign currency on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Short-term investments, fair value Debt Securities, Held-to-Maturity, Fair Value Impairment of long-lived assets Impairment loss Impairment of Intangible Assets, Finite-Lived Deferred tax liabilities Deferred Income Tax Liabilities, Net Accounts payable Accounts Payable, Current Concentration risk Concentration Risk, Percentage Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Commitments and contingencies Commitments and Contingencies Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Components of Other Income Other Nonoperating Income and Expense [Text Block] Stockholders' Equity Equity [Text Block] Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Biopharmaceutical and other revenue Biopharmaceutical And Other [Member] Represents biopharmaceutical. Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Schedule of Future Aggregate Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Other assets Increase (Decrease) in Other Noncurrent Assets Current portion of acquisition-related contingent consideration Short term contingent considerations Business Combination, Contingent Consideration, Liability, Current Income Taxes Income Tax Disclosure [Text Block] Accrued other Other Accrued Liabilities, Current Restricted cash Restricted cash Restricted Cash and Cash Equivalents, Noncurrent Depreciation and amortization Depreciation, Depletion and Amortization Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Customer [Axis] Customer [Axis] Current liabilities: Liabilities, Current [Abstract] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Total stockholders’ equity Balance at beginning of period Balance at end of period Equity, Attributable to Parent Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of September 30, 2023 and December 31, 2022 Preferred Stock, Value, Issued Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Impairment Of Long-Term Assets Impairment Of Long-Term Assets [Member] Impairment of Long-Term Assets Net loss per common share, diluted (in USD per share) Earnings Per Share, Diluted Short-term investments, allowance for expected credit losses Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest HalioDx customer relationships HalioDx Customer Relationships [Member] HalioDx Customer Relationships Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current HalioDx Immunoscore Colon Dx Developed Technology HalioDx Immunoscore Colon Dx Developed Technology [Member] HalioDx Immunoscore Colon Dx Developed Technology Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Change in currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Stock options and restricted stock units issued and outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Trading Symbol Trading Symbol Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Net loss Net loss Net loss Net Income (Loss) Total current liabilities Liabilities, Current Fair Value Disclosures [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Concentrations of Credit Risk and Other Risks and Uncertainties Concentrations Of Credit And Other Risks And Uncertainties [Policy Text Block] Disclosure of accounting policy for concentrations of credit risk and other risks and uncertainties. Noncash lease expense Noncash Lease Expense The noncash portion of lease expense. Total intangible assets Intangible Assets, Gross (Excluding Goodwill) Property, plant and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Lab supplies and reagents consumed Inventory, Finished Goods, Gross Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Employee stock purchase plan Common stock available for the Employee Stock Purchase Plan Employee Stock [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Deferred revenue Contract with Customer, Liability Document Fiscal Period Focus Document Fiscal Period Focus 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Weighted Average Remaining Amortization Period (Years) Finite-Lived Intangible Asset, Useful Life Antidilutive Securities [Axis] Antidilutive Securities [Axis] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Operating lease expense Operating Lease, Expense Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Weighted Average Weighted Average [Member] Common Stock Common Stock [Member] LymphMark product technology LymphMark Product Technology [Member] Represents LymphMark product technology. City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Accrued liabilities and deferred revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Net Loss Per Common Share Earnings Per Share [Text Block] Product and Service [Axis] Product and Service [Axis] Goodwill Goodwill Finance lease, liability, statement of financial position [Extensible List] Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] Equity Components [Axis] Equity Components [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Shares available for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Stock-based compensation expense (non-employee) Adjustments To Additional Paid In Capital, Share Based Compensation, Non Employee Amount of increase In additional paid-in capital (APIC) resulting from non-employee stock-based compensation expense. Document Fiscal Year Focus Document Fiscal Year Focus Entity Small Business Entity Small Business 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Stock-based compensation expense (employee) Adjustments To Additional Paid In Capital, Share Based Compensation, Employee Amount of increase in additional paid-in capital (APIC) resulting from employee stock-based compensation expense. Minimum Minimum [Member] Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable HalioDx developed technology HalioDX Developed Technology [Member] HalioDX Developed Technology Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Accounts receivable Accounts Receivable [Member] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Pension obligation Defined Benefit Plan, Benefit Obligation Assets Assets [Abstract] Operating lease liabilities, net of current portion Long-term lease liabilities Operating Lease, Liability, Noncurrent Thereafter Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Effect of foreign currency on operations Gain (Loss), Foreign Currency Transaction, before Tax Restricted stock units Restricted Stock Units (RSUs) [Member] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Percepta product technology Percepta Product Technology [Member] Percepta Technology [Member] Payment of taxes on vested restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Shares of common stock subject to outstanding options Employee And Non Employee Stock Option [Member] An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, number of shares in the entity at a specified price, as defined in the agreement. Accumulated Deficit Retained Earnings [Member] Customers Representing >10% Of Total Revenue Major Customers [Member] Major Customers Tax portion of vested restricted stock units Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Total liabilities and stockholders’ equity Liabilities and Equity Other assets Other Assets, Noncurrent Schedule of Future Minimum Lease Payments Under Non-cancelable Operating Leases Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Net loss per common share, basic (in USD per share) Earnings Per Share, Basic Right-of-use assets, operating leases Operating Lease, Right-of-Use Asset Issuance of common stock under employee stock purchase plan (ESPP) Stock Issued During Period, Value, Employee Stock Purchase Plan Remainder of 2023 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Equity Interest Issued or Issuable, Type [Domain] Equity Interest Issued or Issuable, Type [Domain] Schedule of Outstanding Common Stock Equivalents Excluded From Diluted Net Loss Per Common Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Product and Service [Domain] Product and Service [Domain] Schedule of Operating Lease Expense and Measurement Of Lease Liabilities Lease, Cost [Table Text Block] Supplies and inventory Increase (Decrease) in Inventories Entity Address, City or Town Entity Address, City or Town Cash paid for tax Income Taxes Paid Award Type [Axis] Award Type [Axis] Common stock equivalents (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Document Quarterly Report Document Quarterly Report Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Purchases of property, plant and equipment included in accounts payable and accrued liability Capital Expenditures Incurred but Not yet Paid Document Transition Report Document Transition Report Short-term investments Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss 2023 remainder of year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Use of Estimates Use of Estimates, Policy [Policy Text Block] Accounts payable Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Entity File Number Entity File Number Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Discount rate Measurement Input, Discount Rate [Member] Current portion of operating lease liabilities Less: short-term lease liabilities Operating Lease, Liability, Current Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Reclassification, Type [Domain] Reclassification, Type [Domain] HalioDx customer backlog HalioDx Customer Backlog [Member] HalioDx Customer Backlog Issuance of common stock under employee stock purchase plan (ESPP) (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Intangible asset amortization Amortization of Intangible Assets Entity Shell Company Entity Shell Company 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Total Finite-Lived Intangible Assets, Net Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] French research tax credits Other Nonoperating Income (Expense), Foreign Tax Credit Foreign Tax Credit, Nonoperating Measurement Input Type [Axis] Measurement Input Type [Axis] Term of lease Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract Schedule of Reserved Shares of Common Stock for Issuance Schedule of Stock by Class [Table Text Block] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Common stock, shares issued (in shares) Common Stock, Shares, Issued Other Other Nonoperating Income (Expense), Other Other Nonoperating Income (Expense), Other Interest income Other Nonoperating Income (Expense), Interest Income Other Nonoperating Income (Expense), Interest Income Current portion of deferred revenue Contract with Customer, Liability, Current Security Exchange Name Security Exchange Name Deferred income taxes Deferred Income Tax Expense (Benefit) Pension Liability Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block] Proceeds from the exercise of common stock options and employee stock purchases Proceeds from Stock Options Exercised Statement of Comprehensive Income [Abstract] Decipher product technology Decipher BioSciences Product Technology [Member] Decipher BioSciences Product Technology Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Finance lease liabilities Finance Lease, Liability Short-Term Investments Investment, Policy [Policy Text Block] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Organization, Description of Business and Summary of Significant Accounting Policies Business Description and Accounting Policies [Text Block] Total operating expenses Costs and Expenses Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Maximum Maximum [Member] Net comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Document Type Document Type Schedule of Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] Additional cash to be paid Business Combination, Contingent Consideration, Cash To Be Paid Business Combination, Contingent Consideration, Cash To Be Paid Stock-based compensation expense (ESPP) Adjustments To Additional Paid In Capital, Share Based Compensation, ESPP Amount of increase in additional paid-in capital (APIC) resulting from ESPP stock-based compensation expense. Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two nCounter Dx license nCounter Dx License [Member] nCounter Dx License [Member] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Decipher trade names Decipher Biosciences Trade Names [Member] Decipher Biosciences Trade Names Revaluation of acquisition-related contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Document Period End Date Document Period End Date Interest on end-of-term debt obligation Debt Instrument, End Of Term Payment Interest Amount And Prepayment Penalty Debt Instrument, End Of Term Payment Interest Amount And Prepayment Penalty Loss on currency revaluation Other Nonoperating Income (Expense), Foreign Currency Translation Gain (Loss) Foreign Currency Translation Gain (Loss), Nonoperating Business Acquisition [Axis] Business Acquisition [Axis] Revenue Revenue from Contract with Customer Benchmark [Member] Realized gains (losses) from sale of short-term investments Debt Security, Held-to-Maturity, Sold, Realized Gain (Loss) Payment of long-term debt Repayments of Long-Term Debt Entity Central Index Key Entity Central Index Key Customer concentration risk Customer Concentration Risk [Member] Loss on disposal of property, plant and equipment Gain (Loss) on Disposition of Property Plant Equipment Current portion of other liabilities Other Liabilities, Current Gross Carrying Amount Finite-Lived Intangible Assets, Gross Income tax benefit Income Tax Expense (Benefit) Prosigna customer relationships Prosigna Customer Relationships [Member] Represents Prosigna customer relationships. Income Statement [Abstract] Income Statement [Abstract] Finance right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Title of 12(b) Security Title of 12(b) Security Accrued compensation expenses Employee-related Liabilities, Current Fair Value Measurements Fair Value Disclosures [Text Block] Number of operating segments Number of Operating Segments Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Revenue Disaggregation of Revenue [Table Text Block] Probability of achievement Measurement Input, Probability Of Achievement [Member] Measurement input using probability of achievement. Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Equity [Abstract] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Class of Stock [Line Items] Class of Stock [Line Items] Income Tax Disclosure [Abstract] Amendment Flag Amendment Flag NanoString NanoString [Member] Represents NanoString. Money Market Funds Money Market Funds [Member] Entity Tax Identification Number Entity Tax Identification Number Supplies and inventory Inventory, Net Proceeds from sale of short-term investments Proceeds from Sale of Held-to-Maturity Securities Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Raw materials and finished diagnostic kits Inventory, Work in Process and Raw Materials Medicare Medicare [Member] Represents Medicare. Discount rate Operating Lease, Weighted Average Discount Rate, Percent Statistical Measurement [Axis] Statistical Measurement [Axis] Testing revenue Testing [Member] Represents testing. Financial Instrument [Axis] Financial Instrument [Axis] Entity Interactive Data Current Entity Interactive Data Current Equity Interest Type [Axis] Equity Interest Type [Axis] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Issuance of common stock on exercise of stock options and vesting of restricted stock units Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Product revenue Product [Member] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Shares used to compute net loss per common share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Facilities in Marseille, France Facilities In Marseille, France [Member] Facilities In Marseille, France Amortized cost of short-term investments sold Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Sold, Amount Schedule of Other Income, net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Proceeds from maturity of short-term investments Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities Accumulated deficit Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Revenue Recognition and Cost of Revenue Revenue from Contract with Customer [Policy Text Block] Operating expenses: Operating Expenses [Abstract] Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Additional paid-in capital Additional Paid in Capital, Common Stock Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Additional Paid-in Capital Additional Paid-in Capital [Member] Current assets: Assets, Current [Abstract] Deposits Deposits for leases Security Deposit Total assets Assets Entity Address, State or Province Entity Address, State or Province Cover [Abstract] Cover [Abstract] Outstanding shares of common stock equivalents that have been excluded from diluted net loss per common share Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Common stock, shares outstanding (in shares) Balance at beginning of period (in shares) Balance at end of period (in shares) Common Stock, Shares, Outstanding Other liabilities Other Liabilities, Noncurrent Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Other Income and Expenses [Abstract] Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Interest expense Other Nonoperating Income (Expense), Interest Expense Interest Expense, Nonoperating Equity Component [Domain] Equity Component [Domain] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Customer [Domain] Customer [Domain] Shares used to compute net loss per common share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Present value of future lease payments Operating Lease, Liability Loss from operations Operating Income (Loss) Measurement Input Type [Domain] Measurement Input Type [Domain] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Total liabilities Liabilities Revenue: Revenues [Abstract] Balance Sheet Related Disclosures [Abstract] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Cost of revenue Cost of Revenue Total number of shares reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Statement [Line Items] Statement [Line Items] Prosigna product technology Developed Product Technology [Member] Developed Product Technology Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Annual rent Lessee, Operating Lease, Lease Not Yet Commenced, Annual Undiscounted Amount Lessee, Operating Lease, Lease Not Yet Commenced, Annual Undiscounted Amount Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] UnitedHealthcare United Healthcare [Member] Represents United Healthcare. Biopharmaceutical revenue Biopharmaceutical And Other - Biopharmaceutical Revenue [Member] Biopharmaceutical And Other - Biopharmaceutical Revenue Earnings Per Share [Abstract] Reclassification, Type [Axis] Reclassification, Type [Axis] Selling and marketing Selling and Marketing Expense Sale of short-term investments Debt Securities, Held-to-Maturity, Sold at Par Value Common stock, $0.001 par value; 125,000,000 shares authorized, 72,993,670 and 71,959,454 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Contingent consideration, changes in fair value Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Business Combination, Contingent Consideration, Liability, Fair Value Adjustment General and administrative General and Administrative Expense Organization, Consolidation and Presentation of Financial Statements [Abstract]